BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21210161)

  • 1. Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study.
    Bock HC; Cohnen J; Keric N; Kantelhardt SR; Giese A
    Acta Neurochir (Wien); 2011 Mar; 153(3):533-9. PubMed ID: 21210161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on Bock et al. Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study. Acta Neurochir (2011) 153:533-539.
    Márquez-Rivas J; Rivero-Garvía M; Mayorga-Buiza MJ
    Acta Neurochir (Wien); 2012 Feb; 154(2):375-6; author reply 377. PubMed ID: 22146843
    [No Abstract]   [Full Text] [Related]  

  • 3. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
    Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A
    Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.
    Subach BR; Witham TF; Kondziolka D; Lunsford LD; Bozik M; Schiff D
    Neurosurgery; 1999 Jul; 45(1):17-22; discussion 22-3. PubMed ID: 10414561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal outcome related to carmustine implants in glioblastoma multiforme.
    Gallego JM; Barcia JA; Barcia-Mariño C
    Acta Neurochir (Wien); 2007 Mar; 149(3):261-5; discussion 265. PubMed ID: 17334672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
    World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma.
    Shibahara I; Miyasaka K; Sekiguchi A; Ishiyama H; Inukai M; Yasui Y; Watanabe T; Sato S; Hide T; Kumabe T
    J Clin Neurosci; 2021 Apr; 86():202-210. PubMed ID: 33775329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of Carmustine wafers after resection of malignant glioma with and without opening of the ventricular system.
    Bettag C; Hussein A; Sachkova A; Bock HC; Mielke D; Rohde V; Abboud T
    J Neurooncol; 2021 Jul; 153(3):519-525. PubMed ID: 34148163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
    Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
    J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
    Limentani SA; Asher A; Heafner M; Kim JW; Fraser R
    J Neurooncol; 2005 May; 72(3):241-4. PubMed ID: 15937647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
    Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
    World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
    McGirt MJ; Villavicencio AT; Bulsara KR; Friedman HS; Friedman AH
    J Neurosurg; 2002 May; 96(5):941-5. PubMed ID: 12005403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Ventricular Opening has No Effect on Complication Development Following BCNU Wafer Implantation for Malignant Glioma.
    Matsuda R; Maeoka R; Tokuda N; Nakazawa T; Morimoto T; Kotsugi M; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Park YS; Nakase H
    World Neurosurg; 2023 Mar; 171():e707-e713. PubMed ID: 36574919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
    Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
    Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
    Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
    J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
    Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
    AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
    Sabel M; Giese A
    Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
    Giese A; Bock HC; Kantelhardt SR; Rohde V
    Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
    Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
    World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.